Breaking News
The AI Bird-Flu Scenario They Just Published
Japan's first robot ambulance works the 9-1-1 lines for humanoids
Cheap smartphone add-on pinpoints hidden cameras to shut down spies
The $600 Tank That Beats a $10,000 Powerwall
Top Tech News
Terrifying AI Behavior Even Its Creators Couldn't Explain
WW3 Near-Miss? AI Hallucinated Nuclear Weapons Components Aboard Chinese Vessel Bound For Iran
Stripe Is Building the Toll Road for the Machine Economy
Toyota Dakar hopeful swaps twin-turbo V6 for hydrogen fuel cells
4-min turbo-inflatable cubic camp castle is now available in the USA
Researchers Used Claude To Hack OpenAI Employee Accounts
Chinese Scientists Develop New Oil Refining Method That Cuts Energy Use by 90%
World's smallest CT scanner fits in the palm of your hand
The Tesla Roadster will blow people's minds
Peter Thiel-Funded Company Anduril to Triple the Number of Autonomous Surveillance Towers...
Aubrey de Grey Thinks Robust Human Longevity Might Be Here by 2037
There is fastly progressing science and there is a rapid increase in funding and formation of companies. Areas that were making slow progress like Mitosens are now rapidly progressing. Cross-linking is making progress as well.
Robust mouse rejuvenation could be only 3 years away instead of five years. Robust mouse rejuvenation could be by 2022.
Aubrey is more optimistic that partial SENS will be able to deliver significant life extension impact.
Aubrey sees a lot of activity in all seven areas of aging damage identified by SENS.
It seems that the removal of senescent cells will deliver useful health benefits and some longevity.
Aubrey indicates that SENS has a fantastic relationship with the Buck Institute. SENS has multiple projects.
Aubrey is working at AgeX as a Vice-president. Previously Aubrey had believed that there was not much need for SENS to fund stem cell research. Aubrey always considered stem cells to be important. Michael West is doing some of the most important work on stem cells.